Latest Investments News

Fitzroy River Corporation reported steady royalty income for the June quarter and highlighted significant progress on several royalty projects, including government approvals for Buru Energy’s Rafael Gas Project and a major equity raise for Endura Mining’s Snowy River Gold development.

INOVIQ Limited has raised $9.5 million to advance its pioneering ovarian cancer screening test and CAR-exosome therapeutic programs, backed by strong preclinical data and strategic partnerships.

Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.

Carlton Investments reported a slight rise in net profit and an 8.7% increase in dividends for FY2025, while its investment portfolio grew nearly 60% over five years despite recent market fluctuations.

Centaurus Metals has secured the Rio Novo Copper-Gold Project adjacent to its Boi Novo asset in Brazil’s prolific Carajás Mineral Province, boosting its regional landholding and exploration potential. The acquisition comes with promising historical drill results and immediate plans to integrate Rio Novo into ongoing exploration efforts.

Nexus Minerals has reported significant new high-grade gold discoveries at its Wallbrook Gold Project, alongside progress in permitting its Crusader-Templar deposit for mining operations.

Ansell Limited delivered a robust FY25 performance driven by organic growth, successful Kimberly-Clark PPE integration, and productivity gains, while advancing sustainability goals and managing trade headwinds.

Helia Group’s 3Q25 APRA data reveals rising gross written premiums despite government scheme pressures, while a Board review confirms strategic focus on the Australian LMI market with significant cost cuts.

Alkane Resources has reported a record quarterly operational cash flow of A$73 million and gold equivalent production of 30,511 ounces, reflecting the successful integration of Mandalay Resources. The company remains on track to meet its full-year guidance amid ongoing exploration and development progress.

Sierra Nevada Gold (ASX, SNX) advances its Nevada gold projects with high-grade results and a new mining permit, while pursuing exploration licenses in Saudi Arabia and raising A$9.65 million in a strategic placement.

Immutep Limited reports strong progress in its Phase III lung cancer trial with over 170 patients enrolled, alongside positive FDA feedback and a robust cash position supporting ongoing development.